The application of LC-Tandem Mass Spectrometry for the low-level determination of estrogens in serum often involves complex sample derivatisation procedures in order to deliver the required level of analytical sensitivity.
This clinical research webinar describes two ground-breaking LC-Tandem mass spectrometry strategies to eliminate sample derivatisation whilst still achieving the required levels of quantitation. In the second part of this presentation, we will explain how sample preparation can be further simplified by exploiting the SelexION™ Differential Ion Mobility Spectrometry device to remove endogenous interfering species whilst maintaining analytical precision and accuracy.
This webinar is suitable for newcomers and established users of LC-Tandem Mass Spectrometry.
The profile of seminar delegates will include biomedical scientists, clinical research scientists as well as laboratory managers from medical research and academic institutions. The thrust of this seminar is designed to show the advances in the data quality obtained by the application of LC-Tandem Mass Spectrometry and Ion Mobility Spectrometry technologies for E1 and E2 quantitation in serum.